RE:GBLC is a CSE psychedelic company I bought bothBe careful with GBLC. I looked at this and they had $67.00 left in cash on their last balance sheet with $740k liabilities. LITT has just under $500k in cash, $1 mil in assets with $440k liabilities. But even if we disregard all that, I like the deals LITT is working on compared to GBLC better. I hope the best for all Psychedelic companies, but right now out of LITT, GBLC, CODE, BOSS, LITT has the best odds with Psilocybin. BOSS has the largest market cap, but it's primarily a weed play that's dabbling in mushrooms, they still trade at a crazy premium to NAV.
I'm and EPS guy and I buy undervalued proven mining assets. But for those that want a chance to actually be part of the next drug therapy movement, so far LITT has the best odds that I've found. If I missed any other plays in this emerging sector, let me know and I would love to check them out.